Allergic rhinitis is an immunologically mediated disease that occurs frequently worldwide and is caused by a type I hypersensitivity reaction (IgE-mediated) to allergenic substances. The clinical symptoms mainly include rhinorrhea (runny nose), sneezing, nasal obstruction (blocked nose), nasal itching and ocular discomfort (red, itchy, watery eyes). Although these symptoms are not usually life-threatening, the quality of life of those affected can be significantly impaired. Many patients also suffer from sleep problems, fatigue and difficulty concentrating, which has a negative impact on their professional performance and social life [1].
You May Also Like
- Phimosis and penile cancer under SGLT2i
Increased risk for men with T2D
- Diabetic ketoacidosis
Recommendations for action in practice
- Migraine: better quality of life thanks to multimodal care
Broader selection of innovative migraine prophylactics and acute therapies
- Therapy of non-tumor-related pain
Do not prescribe opioids lightly for musculoskeletal pain
- Migraine
Fremanezumab for comorbid migraine and depression
- Case study
Moyamoya disease in a 23-year-old female patient
- Dapagliflozin for T2D and heart failure
Epicardial fat reduced in patients with type 2 diabetes and HF
- A hub of biological aging